ANVISA regulation received
02/10/2023
EfA Technologies is proud to announce it received the ANVISA Brazilian regulation for its RevDx product. It is a very exciting result of...
EfA participated in RISE with US, July 2023…
14/08/2023
The program was established last year in collaboration with Philadelphia’s University City Science Center and has grown this year with the addition of...
We had a great time on BioMed 2023
24/05/2023
TMG360 Wrote about us…
06/11/2022
EfA Technologies has developed the revolutionary RevDx diagnostic system used at the point-of-care (POC)—the first mobile technology to allow instant blood analysis anywhere....
We have been to the LSX DigiHealth Leaders 2019 in London
16/12/2019
On the stage at the Health Technology convention – Czech Republic Nov 2019
03/12/2019
Finalist, Trendlines Medtech 2017
22/04/2017
Presenting our RevDx to ambassadors & governmental representatives from all over the world at MASHAV center
02/02/2017